Picture of Conmed logo

CNMD Conmed News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Conmed Corp reports results for the quarter ended in June - Earnings Summary

* Conmed Corp  CNMD.N  reported quarterly adjusted earnings
of 98
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of 83
cents.  The mean expectation of eight analysts for the quarter
was for earnings of 91 cents per share. Wall Street expected
results to range from 88 cents to 99 cents per share.
    * Revenue rose 4.5% to $332.10 million from a year ago;
analysts
expected $332.33 million. 
    * Conmed Corp's reported EPS for the quarter was 96 cents​.
    * The company reported quarterly net income of $29.98
million.
    * Conmed Corp shares had risen by 0.3% this quarter and
lost 36.5%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Conmed Corp is
$88.00 
This summary was machine generated from LSEG data July 31 at
09:53 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.91           0.98           Beat
 Mar. 31 2024      0.74           0.79           Beat
 Dec. 31 2023      1.11           1.06           Missed
 Sep. 30 2023      0.83           0.90           Beat

Recent news on Conmed

See all news